nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—CYP3A7—Vincristine—sarcoma	0.084	0.116	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.084	0.116	CbGbCtD
Trazodone—CYP3A4—Thiotepa—sarcoma	0.083	0.115	CbGbCtD
Trazodone—ABCB1—Dactinomycin—sarcoma	0.0666	0.0919	CbGbCtD
Trazodone—CYP3A5—Vincristine—sarcoma	0.063	0.087	CbGbCtD
Trazodone—ABCB1—Mitoxantrone—sarcoma	0.0596	0.0822	CbGbCtD
Trazodone—CYP3A5—Etoposide—sarcoma	0.0577	0.0797	CbGbCtD
Trazodone—ABCB1—Vincristine—sarcoma	0.041	0.0566	CbGbCtD
Trazodone—ABCB1—Etoposide—sarcoma	0.0376	0.0519	CbGbCtD
Trazodone—CYP3A4—Mitoxantrone—sarcoma	0.0357	0.0493	CbGbCtD
Trazodone—ABCB1—Doxorubicin—sarcoma	0.0256	0.0354	CbGbCtD
Trazodone—CYP3A4—Vincristine—sarcoma	0.0246	0.0339	CbGbCtD
Trazodone—CYP2D6—Doxorubicin—sarcoma	0.0241	0.0333	CbGbCtD
Trazodone—CYP3A4—Etoposide—sarcoma	0.0225	0.0311	CbGbCtD
Trazodone—CYP3A4—Doxorubicin—sarcoma	0.0154	0.0212	CbGbCtD
Trazodone—HTR2A—pulmonary artery—sarcoma	0.00227	0.0902	CbGeAlD
Trazodone—HTR2A—hindlimb—sarcoma	0.00137	0.0546	CbGeAlD
Trazodone—HTR2A—appendage—sarcoma	0.00118	0.0468	CbGeAlD
Trazodone—ORM1—hematopoietic system—sarcoma	0.000775	0.0308	CbGeAlD
Trazodone—HTR2B—myometrium—sarcoma	0.000762	0.0303	CbGeAlD
Trazodone—HTR2A—endothelium—sarcoma	0.000711	0.0283	CbGeAlD
Trazodone—SLC6A4—hematopoietic system—sarcoma	0.00066	0.0262	CbGeAlD
Trazodone—CYP3A7—liver—sarcoma	0.000634	0.0252	CbGeAlD
Trazodone—HTR1A—hematopoietic system—sarcoma	0.000586	0.0233	CbGeAlD
Trazodone—HTR2B—smooth muscle tissue—sarcoma	0.000576	0.0229	CbGeAlD
Trazodone—HTR2B—skin of body—sarcoma	0.000569	0.0226	CbGeAlD
Trazodone—Diplopia—Epirubicin—sarcoma	0.000542	0.00216	CcSEcCtD
Trazodone—Feeling abnormal—Dactinomycin—sarcoma	0.000541	0.00216	CcSEcCtD
Trazodone—Gastrointestinal pain—Thiotepa—sarcoma	0.000541	0.00216	CcSEcCtD
Trazodone—Ill-defined disorder—Etoposide—sarcoma	0.00054	0.00216	CcSEcCtD
Trazodone—ADRA1A—hematopoietic system—sarcoma	0.00054	0.0215	CbGeAlD
Trazodone—CYP3A7-CYP3A51P—liver—sarcoma	0.000539	0.0214	CbGeAlD
Trazodone—Anaemia—Etoposide—sarcoma	0.000538	0.00215	CcSEcCtD
Trazodone—Gastrointestinal pain—Dactinomycin—sarcoma	0.000537	0.00214	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Vincristine—sarcoma	0.000535	0.00213	CcSEcCtD
Trazodone—Hypotension—Mitoxantrone—sarcoma	0.000534	0.00213	CcSEcCtD
Trazodone—Increased appetite—Doxorubicin—sarcoma	0.000534	0.00213	CcSEcCtD
Trazodone—Migraine—Epirubicin—sarcoma	0.000534	0.00213	CcSEcCtD
Trazodone—Insomnia—Vincristine—sarcoma	0.000531	0.00212	CcSEcCtD
Trazodone—Paraesthesia—Vincristine—sarcoma	0.000527	0.0021	CcSEcCtD
Trazodone—Urticaria—Thiotepa—sarcoma	0.000526	0.0021	CcSEcCtD
Trazodone—Malaise—Etoposide—sarcoma	0.000525	0.0021	CcSEcCtD
Trazodone—Vertigo—Etoposide—sarcoma	0.000523	0.00209	CcSEcCtD
Trazodone—Body temperature increased—Thiotepa—sarcoma	0.000523	0.00209	CcSEcCtD
Trazodone—Abdominal pain—Thiotepa—sarcoma	0.000523	0.00209	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000521	0.00208	CcSEcCtD
Trazodone—Body temperature increased—Dactinomycin—sarcoma	0.000519	0.00207	CcSEcCtD
Trazodone—Abdominal pain—Dactinomycin—sarcoma	0.000519	0.00207	CcSEcCtD
Trazodone—Cardiac arrest—Epirubicin—sarcoma	0.000516	0.00206	CcSEcCtD
Trazodone—Paraesthesia—Mitoxantrone—sarcoma	0.000513	0.00205	CcSEcCtD
Trazodone—Loss of consciousness—Etoposide—sarcoma	0.000512	0.00204	CcSEcCtD
Trazodone—Cerebrovascular accident—Doxorubicin—sarcoma	0.000512	0.00204	CcSEcCtD
Trazodone—Lethargy—Doxorubicin—sarcoma	0.000512	0.00204	CcSEcCtD
Trazodone—Decreased appetite—Vincristine—sarcoma	0.00051	0.00204	CcSEcCtD
Trazodone—Ataxia—Epirubicin—sarcoma	0.00051	0.00203	CcSEcCtD
Trazodone—Dyspnoea—Mitoxantrone—sarcoma	0.00051	0.00203	CcSEcCtD
Trazodone—Somnolence—Mitoxantrone—sarcoma	0.000508	0.00203	CcSEcCtD
Trazodone—Fatigue—Vincristine—sarcoma	0.000506	0.00202	CcSEcCtD
Trazodone—Hyponatraemia—Doxorubicin—sarcoma	0.000504	0.00201	CcSEcCtD
Trazodone—Hypertension—Etoposide—sarcoma	0.000503	0.00201	CcSEcCtD
Trazodone—Pain—Vincristine—sarcoma	0.000502	0.002	CcSEcCtD
Trazodone—Constipation—Vincristine—sarcoma	0.000502	0.002	CcSEcCtD
Trazodone—Diplopia—Doxorubicin—sarcoma	0.000502	0.002	CcSEcCtD
Trazodone—Decreased appetite—Mitoxantrone—sarcoma	0.000497	0.00198	CcSEcCtD
Trazodone—ORM1—bone marrow—sarcoma	0.000497	0.0197	CbGeAlD
Trazodone—Chest pain—Etoposide—sarcoma	0.000496	0.00198	CcSEcCtD
Trazodone—Orthostatic hypotension—Epirubicin—sarcoma	0.000495	0.00198	CcSEcCtD
Trazodone—HTR2B—uterus—sarcoma	0.000494	0.0196	CbGeAlD
Trazodone—Migraine—Doxorubicin—sarcoma	0.000494	0.00197	CcSEcCtD
Trazodone—Fatigue—Mitoxantrone—sarcoma	0.000493	0.00197	CcSEcCtD
Trazodone—Discomfort—Etoposide—sarcoma	0.00049	0.00196	CcSEcCtD
Trazodone—Constipation—Mitoxantrone—sarcoma	0.000489	0.00195	CcSEcCtD
Trazodone—Pain—Mitoxantrone—sarcoma	0.000489	0.00195	CcSEcCtD
Trazodone—Hypersensitivity—Thiotepa—sarcoma	0.000488	0.00195	CcSEcCtD
Trazodone—HRH1—myometrium—sarcoma	0.000487	0.0194	CbGeAlD
Trazodone—Hypersensitivity—Dactinomycin—sarcoma	0.000484	0.00193	CcSEcCtD
Trazodone—Gastrointestinal pain—Vincristine—sarcoma	0.00048	0.00191	CcSEcCtD
Trazodone—Confusional state—Etoposide—sarcoma	0.000479	0.00191	CcSEcCtD
Trazodone—ADRA2A—myometrium—sarcoma	0.000478	0.019	CbGeAlD
Trazodone—Cardiac arrest—Doxorubicin—sarcoma	0.000477	0.0019	CcSEcCtD
Trazodone—Asthenia—Thiotepa—sarcoma	0.000475	0.00189	CcSEcCtD
Trazodone—Ataxia—Doxorubicin—sarcoma	0.000472	0.00188	CcSEcCtD
Trazodone—Asthenia—Dactinomycin—sarcoma	0.000471	0.00188	CcSEcCtD
Trazodone—Feeling abnormal—Mitoxantrone—sarcoma	0.000471	0.00188	CcSEcCtD
Trazodone—Pruritus—Thiotepa—sarcoma	0.000468	0.00187	CcSEcCtD
Trazodone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000467	0.00186	CcSEcCtD
Trazodone—Tachycardia—Etoposide—sarcoma	0.000464	0.00185	CcSEcCtD
Trazodone—Body temperature increased—Vincristine—sarcoma	0.000464	0.00185	CcSEcCtD
Trazodone—Abdominal pain—Vincristine—sarcoma	0.000464	0.00185	CcSEcCtD
Trazodone—Hyperhidrosis—Etoposide—sarcoma	0.00046	0.00183	CcSEcCtD
Trazodone—Orthostatic hypotension—Doxorubicin—sarcoma	0.000458	0.00183	CcSEcCtD
Trazodone—Urticaria—Mitoxantrone—sarcoma	0.000454	0.00181	CcSEcCtD
Trazodone—Anorexia—Etoposide—sarcoma	0.000453	0.00181	CcSEcCtD
Trazodone—Diarrhoea—Thiotepa—sarcoma	0.000453	0.00181	CcSEcCtD
Trazodone—Abdominal pain—Mitoxantrone—sarcoma	0.000452	0.0018	CcSEcCtD
Trazodone—Body temperature increased—Mitoxantrone—sarcoma	0.000452	0.0018	CcSEcCtD
Trazodone—Diarrhoea—Dactinomycin—sarcoma	0.000449	0.00179	CcSEcCtD
Trazodone—Hypotension—Etoposide—sarcoma	0.000444	0.00177	CcSEcCtD
Trazodone—Dizziness—Thiotepa—sarcoma	0.000438	0.00175	CcSEcCtD
Trazodone—Pollakiuria—Epirubicin—sarcoma	0.000433	0.00173	CcSEcCtD
Trazodone—HTR2B—tendon—sarcoma	0.000433	0.0172	CbGeAlD
Trazodone—Hypersensitivity—Vincristine—sarcoma	0.000432	0.00173	CcSEcCtD
Trazodone—ADRA2A—seminal vesicle—sarcoma	0.000432	0.0172	CbGeAlD
Trazodone—CYP3A5—hematopoietic system—sarcoma	0.000431	0.0171	CbGeAlD
Trazodone—Photosensitivity reaction—Epirubicin—sarcoma	0.000428	0.00171	CcSEcCtD
Trazodone—Paraesthesia—Etoposide—sarcoma	0.000427	0.0017	CcSEcCtD
Trazodone—Weight increased—Epirubicin—sarcoma	0.000426	0.0017	CcSEcCtD
Trazodone—Weight decreased—Epirubicin—sarcoma	0.000424	0.00169	CcSEcCtD
Trazodone—Dyspnoea—Etoposide—sarcoma	0.000424	0.00169	CcSEcCtD
Trazodone—Somnolence—Etoposide—sarcoma	0.000423	0.00169	CcSEcCtD
Trazodone—Hypersensitivity—Mitoxantrone—sarcoma	0.000421	0.00168	CcSEcCtD
Trazodone—Asthenia—Vincristine—sarcoma	0.000421	0.00168	CcSEcCtD
Trazodone—Vomiting—Thiotepa—sarcoma	0.000421	0.00168	CcSEcCtD
Trazodone—HRH1—hematopoietic system—sarcoma	0.000418	0.0166	CbGeAlD
Trazodone—Drowsiness—Epirubicin—sarcoma	0.000418	0.00167	CcSEcCtD
Trazodone—Vomiting—Dactinomycin—sarcoma	0.000418	0.00167	CcSEcCtD
Trazodone—Rash—Thiotepa—sarcoma	0.000417	0.00167	CcSEcCtD
Trazodone—Dermatitis—Thiotepa—sarcoma	0.000417	0.00166	CcSEcCtD
Trazodone—Headache—Thiotepa—sarcoma	0.000415	0.00165	CcSEcCtD
Trazodone—Rash—Dactinomycin—sarcoma	0.000414	0.00165	CcSEcCtD
Trazodone—Decreased appetite—Etoposide—sarcoma	0.000413	0.00165	CcSEcCtD
Trazodone—ADRA2A—hematopoietic system—sarcoma	0.000411	0.0163	CbGeAlD
Trazodone—Asthenia—Mitoxantrone—sarcoma	0.00041	0.00164	CcSEcCtD
Trazodone—Fatigue—Etoposide—sarcoma	0.00041	0.00164	CcSEcCtD
Trazodone—Jaundice—Epirubicin—sarcoma	0.000407	0.00163	CcSEcCtD
Trazodone—Constipation—Etoposide—sarcoma	0.000407	0.00162	CcSEcCtD
Trazodone—Pain—Etoposide—sarcoma	0.000407	0.00162	CcSEcCtD
Trazodone—HRH1—connective tissue—sarcoma	0.000403	0.016	CbGeAlD
Trazodone—Diarrhoea—Vincristine—sarcoma	0.000402	0.0016	CcSEcCtD
Trazodone—ORM1—liver—sarcoma	0.000401	0.0159	CbGeAlD
Trazodone—Sweating—Epirubicin—sarcoma	0.000401	0.0016	CcSEcCtD
Trazodone—Pollakiuria—Doxorubicin—sarcoma	0.000401	0.0016	CcSEcCtD
Trazodone—Haematuria—Epirubicin—sarcoma	0.000398	0.00159	CcSEcCtD
Trazodone—Photosensitivity reaction—Doxorubicin—sarcoma	0.000396	0.00158	CcSEcCtD
Trazodone—ADRA2A—connective tissue—sarcoma	0.000395	0.0157	CbGeAlD
Trazodone—Weight increased—Doxorubicin—sarcoma	0.000395	0.00157	CcSEcCtD
Trazodone—Nausea—Thiotepa—sarcoma	0.000393	0.00157	CcSEcCtD
Trazodone—Weight decreased—Doxorubicin—sarcoma	0.000392	0.00157	CcSEcCtD
Trazodone—Feeling abnormal—Etoposide—sarcoma	0.000392	0.00156	CcSEcCtD
Trazodone—HTR2A—embryo—sarcoma	0.000391	0.0155	CbGeAlD
Trazodone—Diarrhoea—Mitoxantrone—sarcoma	0.000391	0.00156	CcSEcCtD
Trazodone—Nausea—Dactinomycin—sarcoma	0.00039	0.00156	CcSEcCtD
Trazodone—Gastrointestinal pain—Etoposide—sarcoma	0.000389	0.00155	CcSEcCtD
Trazodone—Dizziness—Vincristine—sarcoma	0.000388	0.00155	CcSEcCtD
Trazodone—Drowsiness—Doxorubicin—sarcoma	0.000387	0.00154	CcSEcCtD
Trazodone—Bradycardia—Epirubicin—sarcoma	0.000382	0.00152	CcSEcCtD
Trazodone—ADRA1A—lymphoid tissue—sarcoma	0.00038	0.0151	CbGeAlD
Trazodone—Urticaria—Etoposide—sarcoma	0.000378	0.00151	CcSEcCtD
Trazodone—Jaundice—Doxorubicin—sarcoma	0.000377	0.0015	CcSEcCtD
Trazodone—Abdominal pain—Etoposide—sarcoma	0.000376	0.0015	CcSEcCtD
Trazodone—Body temperature increased—Etoposide—sarcoma	0.000376	0.0015	CcSEcCtD
Trazodone—Hypoaesthesia—Epirubicin—sarcoma	0.000373	0.00149	CcSEcCtD
Trazodone—Vomiting—Vincristine—sarcoma	0.000373	0.00149	CcSEcCtD
Trazodone—Sweating—Doxorubicin—sarcoma	0.000371	0.00148	CcSEcCtD
Trazodone—Rash—Vincristine—sarcoma	0.00037	0.00148	CcSEcCtD
Trazodone—Dermatitis—Vincristine—sarcoma	0.00037	0.00148	CcSEcCtD
Trazodone—Haematuria—Doxorubicin—sarcoma	0.000369	0.00147	CcSEcCtD
Trazodone—HRH1—smooth muscle tissue—sarcoma	0.000368	0.0146	CbGeAlD
Trazodone—Headache—Vincristine—sarcoma	0.000368	0.00147	CcSEcCtD
Trazodone—Vomiting—Mitoxantrone—sarcoma	0.000363	0.00145	CcSEcCtD
Trazodone—Visual impairment—Epirubicin—sarcoma	0.000361	0.00144	CcSEcCtD
Trazodone—Rash—Mitoxantrone—sarcoma	0.00036	0.00144	CcSEcCtD
Trazodone—Dermatitis—Mitoxantrone—sarcoma	0.00036	0.00144	CcSEcCtD
Trazodone—Headache—Mitoxantrone—sarcoma	0.000358	0.00143	CcSEcCtD
Trazodone—Bradycardia—Doxorubicin—sarcoma	0.000353	0.00141	CcSEcCtD
Trazodone—Hypersensitivity—Etoposide—sarcoma	0.00035	0.0014	CcSEcCtD
Trazodone—Tinnitus—Epirubicin—sarcoma	0.00035	0.0014	CcSEcCtD
Trazodone—HTR2A—hematopoietic system—sarcoma	0.000349	0.0139	CbGeAlD
Trazodone—Nausea—Vincristine—sarcoma	0.000349	0.00139	CcSEcCtD
Trazodone—Flushing—Epirubicin—sarcoma	0.000348	0.00139	CcSEcCtD
Trazodone—Hypoaesthesia—Doxorubicin—sarcoma	0.000345	0.00138	CcSEcCtD
Trazodone—Asthenia—Etoposide—sarcoma	0.000341	0.00136	CcSEcCtD
Trazodone—Nausea—Mitoxantrone—sarcoma	0.000339	0.00135	CcSEcCtD
Trazodone—Chills—Epirubicin—sarcoma	0.000337	0.00134	CcSEcCtD
Trazodone—Pruritus—Etoposide—sarcoma	0.000336	0.00134	CcSEcCtD
Trazodone—HTR2A—connective tissue—sarcoma	0.000336	0.0134	CbGeAlD
Trazodone—Arrhythmia—Epirubicin—sarcoma	0.000335	0.00134	CcSEcCtD
Trazodone—Visual impairment—Doxorubicin—sarcoma	0.000334	0.00133	CcSEcCtD
Trazodone—Alopecia—Epirubicin—sarcoma	0.000331	0.00132	CcSEcCtD
Trazodone—Diarrhoea—Etoposide—sarcoma	0.000325	0.0013	CcSEcCtD
Trazodone—Tinnitus—Doxorubicin—sarcoma	0.000324	0.00129	CcSEcCtD
Trazodone—CYP3A4—hematopoietic system—sarcoma	0.000323	0.0128	CbGeAlD
Trazodone—Flushing—Doxorubicin—sarcoma	0.000322	0.00129	CcSEcCtD
Trazodone—Flatulence—Epirubicin—sarcoma	0.000322	0.00128	CcSEcCtD
Trazodone—Tension—Epirubicin—sarcoma	0.00032	0.00128	CcSEcCtD
Trazodone—Dysgeusia—Epirubicin—sarcoma	0.00032	0.00128	CcSEcCtD
Trazodone—CYP2D6—hematopoietic system—sarcoma	0.000318	0.0126	CbGeAlD
Trazodone—Nervousness—Epirubicin—sarcoma	0.000317	0.00127	CcSEcCtD
Trazodone—Back pain—Epirubicin—sarcoma	0.000316	0.00126	CcSEcCtD
Trazodone—Dizziness—Etoposide—sarcoma	0.000314	0.00125	CcSEcCtD
Trazodone—ADRA2A—cardiac atrium—sarcoma	0.000312	0.0124	CbGeAlD
Trazodone—Chills—Doxorubicin—sarcoma	0.000311	0.00124	CcSEcCtD
Trazodone—ADRA2A—uterus—sarcoma	0.00031	0.0123	CbGeAlD
Trazodone—Arrhythmia—Doxorubicin—sarcoma	0.00031	0.00124	CcSEcCtD
Trazodone—Vision blurred—Epirubicin—sarcoma	0.000308	0.00123	CcSEcCtD
Trazodone—ORM1—lymph node—sarcoma	0.000308	0.0122	CbGeAlD
Trazodone—HTR2A—smooth muscle tissue—sarcoma	0.000308	0.0122	CbGeAlD
Trazodone—Alopecia—Doxorubicin—sarcoma	0.000307	0.00122	CcSEcCtD
Trazodone—Ill-defined disorder—Epirubicin—sarcoma	0.000303	0.00121	CcSEcCtD
Trazodone—Vomiting—Etoposide—sarcoma	0.000302	0.00121	CcSEcCtD
Trazodone—Anaemia—Epirubicin—sarcoma	0.000302	0.0012	CcSEcCtD
Trazodone—Agitation—Epirubicin—sarcoma	0.0003	0.0012	CcSEcCtD
Trazodone—Rash—Etoposide—sarcoma	0.0003	0.0012	CcSEcCtD
Trazodone—Dermatitis—Etoposide—sarcoma	0.000299	0.00119	CcSEcCtD
Trazodone—Headache—Etoposide—sarcoma	0.000298	0.00119	CcSEcCtD
Trazodone—Flatulence—Doxorubicin—sarcoma	0.000298	0.00119	CcSEcCtD
Trazodone—Tension—Doxorubicin—sarcoma	0.000296	0.00118	CcSEcCtD
Trazodone—Dysgeusia—Doxorubicin—sarcoma	0.000296	0.00118	CcSEcCtD
Trazodone—Malaise—Epirubicin—sarcoma	0.000294	0.00117	CcSEcCtD
Trazodone—Nervousness—Doxorubicin—sarcoma	0.000293	0.00117	CcSEcCtD
Trazodone—Vertigo—Epirubicin—sarcoma	0.000293	0.00117	CcSEcCtD
Trazodone—Syncope—Epirubicin—sarcoma	0.000293	0.00117	CcSEcCtD
Trazodone—Back pain—Doxorubicin—sarcoma	0.000292	0.00117	CcSEcCtD
Trazodone—Palpitations—Epirubicin—sarcoma	0.000289	0.00115	CcSEcCtD
Trazodone—Loss of consciousness—Epirubicin—sarcoma	0.000287	0.00115	CcSEcCtD
Trazodone—Vision blurred—Doxorubicin—sarcoma	0.000285	0.00114	CcSEcCtD
Trazodone—Nausea—Etoposide—sarcoma	0.000282	0.00113	CcSEcCtD
Trazodone—Hypertension—Epirubicin—sarcoma	0.000282	0.00112	CcSEcCtD
Trazodone—Ill-defined disorder—Doxorubicin—sarcoma	0.00028	0.00112	CcSEcCtD
Trazodone—ADRA1A—liver—sarcoma	0.00028	0.0111	CbGeAlD
Trazodone—Anaemia—Doxorubicin—sarcoma	0.000279	0.00111	CcSEcCtD
Trazodone—Arthralgia—Epirubicin—sarcoma	0.000278	0.00111	CcSEcCtD
Trazodone—Myalgia—Epirubicin—sarcoma	0.000278	0.00111	CcSEcCtD
Trazodone—Chest pain—Epirubicin—sarcoma	0.000278	0.00111	CcSEcCtD
Trazodone—Agitation—Doxorubicin—sarcoma	0.000278	0.00111	CcSEcCtD
Trazodone—Anxiety—Epirubicin—sarcoma	0.000277	0.00111	CcSEcCtD
Trazodone—HRH1—tendon—sarcoma	0.000277	0.011	CbGeAlD
Trazodone—Discomfort—Epirubicin—sarcoma	0.000275	0.0011	CcSEcCtD
Trazodone—Malaise—Doxorubicin—sarcoma	0.000272	0.00109	CcSEcCtD
Trazodone—Dry mouth—Epirubicin—sarcoma	0.000272	0.00108	CcSEcCtD
Trazodone—ADRA2A—tendon—sarcoma	0.000272	0.0108	CbGeAlD
Trazodone—Vertigo—Doxorubicin—sarcoma	0.000271	0.00108	CcSEcCtD
Trazodone—Syncope—Doxorubicin—sarcoma	0.000271	0.00108	CcSEcCtD
Trazodone—Confusional state—Epirubicin—sarcoma	0.000269	0.00107	CcSEcCtD
Trazodone—Palpitations—Doxorubicin—sarcoma	0.000267	0.00107	CcSEcCtD
Trazodone—ABCB1—myometrium—sarcoma	0.000267	0.0106	CbGeAlD
Trazodone—Oedema—Epirubicin—sarcoma	0.000266	0.00106	CcSEcCtD
Trazodone—Loss of consciousness—Doxorubicin—sarcoma	0.000266	0.00106	CcSEcCtD
Trazodone—Shock—Epirubicin—sarcoma	0.000262	0.00105	CcSEcCtD
Trazodone—Hypertension—Doxorubicin—sarcoma	0.000261	0.00104	CcSEcCtD
Trazodone—Tachycardia—Epirubicin—sarcoma	0.00026	0.00104	CcSEcCtD
Trazodone—HTR2B—lymph node—sarcoma	0.00026	0.0103	CbGeAlD
Trazodone—Hyperhidrosis—Epirubicin—sarcoma	0.000258	0.00103	CcSEcCtD
Trazodone—Arthralgia—Doxorubicin—sarcoma	0.000257	0.00103	CcSEcCtD
Trazodone—Chest pain—Doxorubicin—sarcoma	0.000257	0.00103	CcSEcCtD
Trazodone—Myalgia—Doxorubicin—sarcoma	0.000257	0.00103	CcSEcCtD
Trazodone—ABCB1—embryo—sarcoma	0.000256	0.0102	CbGeAlD
Trazodone—Anxiety—Doxorubicin—sarcoma	0.000256	0.00102	CcSEcCtD
Trazodone—Discomfort—Doxorubicin—sarcoma	0.000254	0.00101	CcSEcCtD
Trazodone—Anorexia—Epirubicin—sarcoma	0.000254	0.00101	CcSEcCtD
Trazodone—Dry mouth—Doxorubicin—sarcoma	0.000252	0.001	CcSEcCtD
Trazodone—Hypotension—Epirubicin—sarcoma	0.000249	0.000994	CcSEcCtD
Trazodone—Confusional state—Doxorubicin—sarcoma	0.000249	0.000992	CcSEcCtD
Trazodone—Oedema—Doxorubicin—sarcoma	0.000247	0.000984	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000243	0.000969	CcSEcCtD
Trazodone—Shock—Doxorubicin—sarcoma	0.000243	0.000968	CcSEcCtD
Trazodone—Insomnia—Epirubicin—sarcoma	0.000241	0.000962	CcSEcCtD
Trazodone—ABCB1—seminal vesicle—sarcoma	0.000241	0.00957	CbGeAlD
Trazodone—Tachycardia—Doxorubicin—sarcoma	0.000241	0.00096	CcSEcCtD
Trazodone—Paraesthesia—Epirubicin—sarcoma	0.000239	0.000955	CcSEcCtD
Trazodone—Hyperhidrosis—Doxorubicin—sarcoma	0.000238	0.000951	CcSEcCtD
Trazodone—Dyspnoea—Epirubicin—sarcoma	0.000238	0.000948	CcSEcCtD
Trazodone—Somnolence—Epirubicin—sarcoma	0.000237	0.000945	CcSEcCtD
Trazodone—Anorexia—Doxorubicin—sarcoma	0.000235	0.000938	CcSEcCtD
Trazodone—Decreased appetite—Epirubicin—sarcoma	0.000232	0.000924	CcSEcCtD
Trazodone—HTR2A—tendon—sarcoma	0.000231	0.00918	CbGeAlD
Trazodone—Hypotension—Doxorubicin—sarcoma	0.00023	0.000919	CcSEcCtD
Trazodone—Fatigue—Epirubicin—sarcoma	0.00023	0.000917	CcSEcCtD
Trazodone—HRH1—testis—sarcoma	0.000229	0.00911	CbGeAlD
Trazodone—ABCB1—hematopoietic system—sarcoma	0.000229	0.00909	CbGeAlD
Trazodone—Pain—Epirubicin—sarcoma	0.000228	0.000909	CcSEcCtD
Trazodone—Constipation—Epirubicin—sarcoma	0.000228	0.000909	CcSEcCtD
Trazodone—ADRA2A—testis—sarcoma	0.000225	0.00894	CbGeAlD
Trazodone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000225	0.000896	CcSEcCtD
Trazodone—CYP3A5—liver—sarcoma	0.000223	0.00887	CbGeAlD
Trazodone—Insomnia—Doxorubicin—sarcoma	0.000223	0.00089	CcSEcCtD
Trazodone—Paraesthesia—Doxorubicin—sarcoma	0.000221	0.000883	CcSEcCtD
Trazodone—Dyspnoea—Doxorubicin—sarcoma	0.00022	0.000877	CcSEcCtD
Trazodone—Feeling abnormal—Epirubicin—sarcoma	0.00022	0.000876	CcSEcCtD
Trazodone—Somnolence—Doxorubicin—sarcoma	0.000219	0.000875	CcSEcCtD
Trazodone—Gastrointestinal pain—Epirubicin—sarcoma	0.000218	0.000869	CcSEcCtD
Trazodone—Decreased appetite—Doxorubicin—sarcoma	0.000214	0.000855	CcSEcCtD
Trazodone—Fatigue—Doxorubicin—sarcoma	0.000213	0.000848	CcSEcCtD
Trazodone—Urticaria—Epirubicin—sarcoma	0.000212	0.000845	CcSEcCtD
Trazodone—Pain—Doxorubicin—sarcoma	0.000211	0.000841	CcSEcCtD
Trazodone—Constipation—Doxorubicin—sarcoma	0.000211	0.000841	CcSEcCtD
Trazodone—Abdominal pain—Epirubicin—sarcoma	0.000211	0.000841	CcSEcCtD
Trazodone—Body temperature increased—Epirubicin—sarcoma	0.000211	0.000841	CcSEcCtD
Trazodone—Feeling abnormal—Doxorubicin—sarcoma	0.000203	0.000811	CcSEcCtD
Trazodone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000202	0.000805	CcSEcCtD
Trazodone—Hypersensitivity—Epirubicin—sarcoma	0.000196	0.000783	CcSEcCtD
Trazodone—Urticaria—Doxorubicin—sarcoma	0.000196	0.000782	CcSEcCtD
Trazodone—Abdominal pain—Doxorubicin—sarcoma	0.000195	0.000778	CcSEcCtD
Trazodone—Body temperature increased—Doxorubicin—sarcoma	0.000195	0.000778	CcSEcCtD
Trazodone—HTR2A—testis—sarcoma	0.000191	0.0076	CbGeAlD
Trazodone—Asthenia—Epirubicin—sarcoma	0.000191	0.000763	CcSEcCtD
Trazodone—Pruritus—Epirubicin—sarcoma	0.000189	0.000752	CcSEcCtD
Trazodone—Diarrhoea—Epirubicin—sarcoma	0.000182	0.000728	CcSEcCtD
Trazodone—Hypersensitivity—Doxorubicin—sarcoma	0.000182	0.000725	CcSEcCtD
Trazodone—HTR2A—liver—sarcoma	0.000181	0.00719	CbGeAlD
Trazodone—Asthenia—Doxorubicin—sarcoma	0.000177	0.000706	CcSEcCtD
Trazodone—Dizziness—Epirubicin—sarcoma	0.000176	0.000703	CcSEcCtD
Trazodone—Pruritus—Doxorubicin—sarcoma	0.000174	0.000696	CcSEcCtD
Trazodone—CYP2D6—testis—sarcoma	0.000174	0.00693	CbGeAlD
Trazodone—ABCB1—uterus—sarcoma	0.000173	0.00687	CbGeAlD
Trazodone—Vomiting—Epirubicin—sarcoma	0.000169	0.000676	CcSEcCtD
Trazodone—Diarrhoea—Doxorubicin—sarcoma	0.000169	0.000673	CcSEcCtD
Trazodone—Rash—Epirubicin—sarcoma	0.000168	0.00067	CcSEcCtD
Trazodone—Dermatitis—Epirubicin—sarcoma	0.000168	0.00067	CcSEcCtD
Trazodone—CYP3A4—liver—sarcoma	0.000167	0.00666	CbGeAlD
Trazodone—Headache—Epirubicin—sarcoma	0.000167	0.000666	CcSEcCtD
Trazodone—HRH1—lymph node—sarcoma	0.000166	0.0066	CbGeAlD
Trazodone—CYP2D6—liver—sarcoma	0.000165	0.00655	CbGeAlD
Trazodone—ADRA2A—lymph node—sarcoma	0.000163	0.00648	CbGeAlD
Trazodone—Dizziness—Doxorubicin—sarcoma	0.000163	0.000651	CcSEcCtD
Trazodone—ABCB1—lymphoid tissue—sarcoma	0.000161	0.0064	CbGeAlD
Trazodone—Nausea—Epirubicin—sarcoma	0.000158	0.000632	CcSEcCtD
Trazodone—Vomiting—Doxorubicin—sarcoma	0.000157	0.000626	CcSEcCtD
Trazodone—Rash—Doxorubicin—sarcoma	0.000155	0.00062	CcSEcCtD
Trazodone—Dermatitis—Doxorubicin—sarcoma	0.000155	0.00062	CcSEcCtD
Trazodone—Headache—Doxorubicin—sarcoma	0.000154	0.000616	CcSEcCtD
Trazodone—ABCB1—bone marrow—sarcoma	0.000147	0.00583	CbGeAlD
Trazodone—Nausea—Doxorubicin—sarcoma	0.000146	0.000584	CcSEcCtD
Trazodone—ABCB1—testis—sarcoma	0.000125	0.00498	CbGeAlD
Trazodone—ABCB1—liver—sarcoma	0.000119	0.00471	CbGeAlD
Trazodone—ABCB1—lymph node—sarcoma	9.09e-05	0.00361	CbGeAlD
